Purification and Characterization of an Allergy-induced Melanogenic Stimulating Factor in Brownish Guinea Pig Skin*

Genji ImokawaDagger §, K. HiguchiDagger , and Y. Yada

From the Dagger  Biological Science Laboratories and  Tokyo Research Laboratories, Kao Corporation, Ichikaimachi 2606, Tochigi 321-34, and Bunka 2-chome, Sumida-ku, Tokyo 131 Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We have demonstrated recently that phenylazonaphthol (PAN) allergy-induced hyperpigmentation in brownish guinea pig skin is associated with the concomitant appearance of a melanogenic soluble factor(s) that activates the intracellular signal transduction system, including phosphatidylinositol turnover subsequent to ligand-receptor binding in cultured guinea pig melanocytes. In this study we have purified and characterized the PAN-induced melanogenic stimulating factor (PIMSF) that occurs in allergy-associated hyperpigmented skin. By successive column chromatography on TSK 2000SW, Mono Q, and octadecyl-NPR, the PIMSF was purified to homogeneity with a single band of apparent molecular mass of 7.9 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The specific bioactivity of PIMSF increased by 5,195-fold over the original skin homogenate. In cultured guinea pig melanocytes, this purified PIMSF had the potential of activating an intracellular signal transduction system such as inositol 1,4,5-trisphosphate formation and intracellular calcium levels through a pertussis toxin-sensitive G protein-coupled receptor. PIMSF consistently caused a rapid translocation of cytosolic protein kinase C (PKC) to membrane-bound PKC within 5 min of treatment with a return to the basal level after 120 min. The stimulating effects of PIMSF on proliferation and melanization of cultured guinea pig melanocytes were abolished completely by a PKC down-regulating agent (phorbol 12,13-dibutyrate). PIMSF was similar in molecular mass to rat growth-related oncogene alpha  (GRO-alpha ; molecular mass of 7.9 kDa) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and had immunocross-reactivity with GRO-alpha upon Western immune blotting analysis. Further, the stimulatory effect of purified PIMSF on DNA synthesis of cultured guinea pig melanocytes was suppressed markedly by the addition of anti-rat GRO-alpha antibody, implying that the PIMSF is apparently identical to GRO-alpha . These findings suggest that PAN allergy provides a new mechanism of hyperpigmentation in which biological factors such as the GRO-alpha superfamily generated within allergy-induced skin stimulate melanocytes through activation of the PKC-related signal transduction pathway.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Phenylazonaphthol (PAN)1 allergy-induced late appearing hyperpigmentation is known as pigmented cosmetic dermatitis (1). We demonstrated previously that specific melanogenic factors produced after a time course of hyperpigmentation due to PAN allergy in brownish guinea pig skin are associated with the induction of epidermal hyperpigmentation by the allergen (2). Biological evidence of signal transduction profiles suggested that melanogenic stimulation induced by PAN allergy is mediated through protein kinase C (PKC) activation within melanocytes by soluble factors secreted during biologic processing subsequent to allergic reaction (2).

Evidence has accumulated demonstrating that chemical mediators such as arachidonic metabolites (3, 4) or growth factor-like substances (5) secreted during inflammation could be responsible for stimulating the function and population of melanocytes, leading to hyperpigmentation induced by several stimuli including ultraviolet (UV) light. However, few of these mediators are known as intrinsic cytokines responsible for hyperpigmentation in vivo. We demonstrated previously that endothelins (ET) secreted from human keratinocytes act as intrinsic mitogens and melanogens for human melanocytes in UVB-induced melanosis (6-8). Furthermore, UVA-induced melanosis is associated with other keratinocyte-derived growth factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF), secretion of which is specifically stimulated after exposure of human keratinocytes to UVA (9). It is thus likely that the paracrine linkage of cytokines between keratinocytes and melanocytes in the epidermis plays a constitutive role in stimuli-induced cutaneous pigmentation.

PAN allergy-induced hyperpigmentation clearly differs in its time course from ET or GM-CSF-associated pigmentation such as UVB or UVA melanosis, respectively (1, 10). Further, there is no similarity in the chromatographic properties between the relevant cytokines in that the allergy-evoked soluble factor exhibits an apparent molecular mass of about 8-9 kDa estimated by gel filtration, which is distinct from that of ET-1 (2.3-2.7 kDa) or GM-CSF (14.5-15.5 kDa).

Aside from studies focusing on the biological effects of exogenously added cytokines on human melanocytes (11), studies examining the paracrine linkage of cytokines between keratinocytes and melanocytes would provide new insight into cellular mechanisms involved with intrinsic that which eventually take part in allergy-induced melanosis. Our previous studies (7, 9) suggested that different stimuli, including UV irradiation, trigger keratinocytes in various ways to produce and secrete completely different spectra of growth factors. On the other hand, it is likely that melanocytes undergo proliferation and differentiation in a similar fashion when responding to different growth factors secreted from keratinocytes (12). In this study therefore, we have extended our previous work and have purified a 7.9-kDa polypeptide from guinea pig skin, and we have characterized its effects on melanocytes. We identified this factor to be a member of the growth-related oncogene alpha  (GRO-alpha ) family or very close to it. It seems likely that specific melanogenic factors, such as GRO-alpha , produced in allergic cutaneous inflammation are responsible for the induction of late appearing hyperpigmentation by PAN allergy.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials

Anti-ET-1 and anti-rat GRO-a antibodies were purchased from Immunobiological Laboratories Co., Ltd. (Gunma, Japan). Anti-bFGF was obtained from Oncogene Science Inc. (Manhasset, NY). Fetal calf serum and minimal essential medium (MEM) were purchased from Life Technologies, Inc. Other chemicals were of reagent grade.

Melanocyte Culture

Guinea pig melanocytes were established from the flank skin of newborn brownish guinea pigs. Briefly, epidermal sheets were peeled from the skin after incubation with 1,500-2,000 units/ml dispase at 37 °C for 2 h and at room temperature for another 2 h. The epidermal cells were then dispersed by treatment with 0.05% trypsin and 0.02% EDTA at 37 °C for 30 min. The suspension of epidermal cells was filtered through sterilized gauze to remove stratum corneum layers; after centrifugation at 800 × g for 10 min, the suspension was cultured in 250-cm2 Falcon dishes with MEM supplemented with 10% fetal calf serum, 10 mM nonessential amino acids, 100 units/ml penicillin, 100 µg/ml streptomycin, 0.5 mg/ml Fungizone, 16 nM phorbol 12-myristate 13-acetate (PMA), and 10 µM cholera toxin. After 24-48 h of primary culture, the medium was replaced with new medium containing 100 µg/ml Geneticin, and the culture was continued for 7-10 days to remove contaminating fibroblasts. After removal of fibroblasts, melanocytes were cultured in medium without Geneticin for 45-60 days with medium exchange every 3 days. For the first 2 months, melanocytes were subcultured by trypsin treatment every week. After the melanocytes began to grow well, melanocyte cultures were carried out in MEM (supplemented with 10% fetal calf serum, 10 mM nonessential amino acids, 100 units/ml penicillin, 100 µg/ml streptomycin) (MCM) excluding PMA and cholera toxin.

Assay of Melanogenesis

Melanocytes were cultured in the MCM excluding PMA and cholera toxin for more than 1 week. After trypsin treatment they were seeded into 24-well culture plates at a concentration of 1-2 × 104 cells/ml in the MCM. After a 24-h culture, the medium was exchanged for MEM (without fetal calf serum) supplemented with antibiotics, and fraction samples or purified PAN-induced melanogenic stimulating factor (PIMSF) was added at a 100 µl/ml or 1 ng/ml concentration, respectively. For assay of melanin formation (12, 13), [2-14C]thiouracil was diluted in Hanks' solution and added at 0.5 µCi/ml/well in culture for 24 h at 37 °C. Incorporated labeled thiouracil was counted by a liquid scintillation counter after the cells were washed twice with phosphate-buffered saline (PBS-)) followed by trichloroacetic acid treatment and solubilization with 1 N NaOH. In experiments to measure tyrosinase activity (2), L-[3,5-3H]tyrosine was diluted in Hanks' solution and added at 1.0 µCi/ml/well to the melanocyte culture plates. After culture for 24 h, 500 µl of medium was transferred to test tubes into which trichloroacetic acid was added to a final concentration of 10%. After incubation for 1 h at 4 °C and centrifugation, these supernatants were subjected to Dowex 50W-X12 (50-100 mesh) ion exchange columns (2 ml) to remove unreacted tyrosine, followed by elution with 1 ml of distilled water. 500 µl of the eluted radioactive water was measured by liquid scintillation counter.

DNA Synthesis

DNA synthesis of melanocytes was measured by the incorporation of [3H]thymidine (Amersham InH, Bucks, U. K.). Melanocytes were plated in 24-well culture dishes at 1-2 × 104 cells/ml in the MCM excluding PMA and cholera toxin. After a 24-h culture, the medium was exchanged for MEM (without fetal calf serum) supplemented with antibiotics; 50 µl of chromatographic fractions from skin extracts was added to the melanocyte cultures for 24 h at 100 µl/ml concentration, and the cells were pulse labeled with 1.0 µCi/ml [3H]thymidine for the last 4 h of the 24-h incubation period. After three washings with PBS(-), the cells were lysed with 2 N NaOH at 37 °C for 15 min and neutralized with an equal volume of 2 N HCl. Acid-insoluble materials were precipitated by the addition of 4 volumes of ice-cold 10% trichloroacetic acid, collected on glass microfilters, washed three times with 10% trichloroacetic acid, once with ethanol, and then dried. Incorporated labeled thymidine was counted by a liquid scintillation counter.

Measurement of Mass Contents of Ins(1,4,5,)P3

For inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) assay (6), cells were seeded in 24-well culture dishes at a density of 3 × 104 cells/ml and cultured in MCM excluding PMA and cholera toxin for 24 h. The media were then aspirated. MEM containing 10 mM LiCl was added and incubated for 10 min at 37 °C before stimulation with skin extract. The stimulation by skin extract was terminated at the designated times by adding 10% perchloric acid after which the samples were kept on ice for 15 min. After neutralization with ice-cold 1.5 M KOH for 60 min on ice, the samples were centrifuged at 2,000 × g for 10 min to remove the KClO4 precipitate. The supernatant samples (100 µl each) were subjected to Ins(1,4,5)P3 assay using an inositol trisphosphate assay kit (Amersham) (14, 15). The Ins(1,4,5)P3 content was determined quantitatively from a calibration curve by using the binding protein specific for Ins(1,4,5)P3 and [3H]Ins(1,4,5)P3.

Measurement of Intracellular Calcium Content

The melanocytes (2 × 103 cells/dish) were loaded with the calcium indicator Fura-2/AM (2 µM) by incubation for 30 min at 37 °C in the MCM excluding PMA and cholera toxin. The cultured cells were washed twice with fresh medium and exposed in MEM (without fetal calf serum) to purified PIMSF at a 1 µg/ml concentration. Fluorescence images were obtained at alternating excitation wavelengths of 340 and 380 nm through a SIT vidicon camera and processed using an Argus-200 image analyzer (Hamamatsu Photonics Corp., Hamamatsu, Japan). The calibration of the fluorescent signal in terms of the intracellular Ca2+ concentration was performed using digital imaging microscopy as described previously (6). Pertussis toxin was added at a concentration of 100 ng/ml 15 h before incubation with 1 µg/ml concentration of purified PIMSF.

Preparation of Skin Extract

The discs of guinea pig skin biopsied by keratotome, mainly consisting of epidermis, were homogenized in a 5-fold volume of ice-cold phosphate buffer, pH 7.4, containing 1 mM phenylmethylsulfonyl fluoride using a Polytron homogenizer chilled with ice. After removing unbroken tissues by centrifugation at 800 × g for 10 min, the supernatant fraction was subjected to further centrifugation at 105,000 × g for 60 min to obtain skin extract for further biochemical assay.

Purification of PIMSF

All procedures were carried out at 4 °C unless otherwise indicated.

TSK 2000SW Column Chromatography-- 1 ml of skin extract was applied to a TSK 2000SW column (21.5 × 600 mm, Toyo Soda, Tokyo, Japan) equilibrated with PBS. Elution was performed with the same buffer at a flow rate of 5 ml/min, and 1.0-ml fractions were collected under the control of an HRLC Bio-Dimension System (Bio-Rad Laboratories). Melanogenic and proliferative activities of each fraction were evaluated for a 24-h incubation period at a 100 µl/ml concentration according to the methods described above, and active fractions were pooled.

Mono Q Ion Exchange Column Chromatography-- The pooled active fractions were applied to a Mono Q ion exchange column (HR 10/10, Pharmacia Biotech Inc.) equilibrated with 160 mM phosphate buffer, pH 7.4. The proteins were eluted at a flow rate of 3.0 ml/min with an increasing NaCl gradient from 0 to 1.0 M over 30 min, using the HRLC Bio-Dimension System. Fractions of 1.0 ml were collected, assayed as above, and active fractions were pooled.

Octadecyl-NPR Column Chromatography-- The active fractions obtained from the Mono Q column were applied to an octadecyl-NPR column (HR, Toyo Soda). The proteins were eluted at a flow rate of 1.0 ml/min with an increasing acetonitrile (containing 0.03% trifluoroacetic acid) gradient of 0-100% over 30 min. Fractions of 0.5 ml were collected and assayed as above. The active fractions were pooled and were dialyzed for 20 h against 2 liters of 160 mM phosphate buffer, pH 7.4. The dialyzed active samples were concentrated to about 0.5-0.8 ml in Centricon 3 (Amicon, Millipore Corp., Bedford, MA).

Mono Q Ion Exchange Column Rechromatography-- The concentrated active fractions were applied to a Mono Q ion exchange column (HR 5/5, Pharmacia) equilibrated with 160 mM phosphate buffer, pH 7.4. The proteins were eluted at a flow rate of 1.0 ml/min with an increasing NaCl gradient of 0-1.0 M over 30 min, using the HRLC Bio-Dimension System. Fractions of 0.5 ml were collected and assayed as above, and active fractions were pooled.

TSK 2000SW Column Rechromatography-- The active fraction obtained from the Mono Q column was applied to a TSK 2000SW column (7.5 × 600 mm) equilibrated with PBS. Elution was performed with PBS at a flow rate of 0.6 ml/min, and 0.3-ml fractions were collected and assayed. Active fractions were pooled.

Measurement of PKC Activity and Translocation

The cultured melanocytes were incubated in MEM (without fetal calf serum) with purified PIMSF at 37 °C for the times indicated, washed twice with cold PBS, and scraped from the culture dishes. The cell suspensions were centrifuged for 5 min at 200 × g and resuspended in 25 mM Tris/HCl buffer, pH 7.5, containing 2 mM EGTA, 5 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride. Cytosol and membrane fractions were prepared as described previously (14). PKC activity was assayed by measuring the incorporation of 32P from [gamma -32P]ATP into histone H-1 (type III-S) as described (14).

Other Methods

Analytical sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed by the method of Laemmli (16) in 5-20% gradient polyacrylamide gels. For Western immunoblotting analysis, purified proteins as detailed before were separated on 5-20% gradient SDS gels and then transferred to nitrocellulose membrane sheets or polyvinylidene difluoride membranes (Immobilon-P, Millipore Corp.) and incubated with primary antibodies (1/1,000 dilution). Subsequent visualization of antibody binding was carried out with an ABC kit (Funakoshi, Tokyo, Japan) according to the manufacturer's instructions. Protein concentrations were determined using Bio-Rad protein assay kits with bovine serum albumin as the standard.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Purification of Melanogenic Soluble Factors-- In previous studies we reported that DNA synthesis (as measured by [3H]thymidine incorporation) and melanogenesis (as measured by tyrosinase assay and melanin formation) of cultured guinea pig melanocytes were stimulated by the addition of skin extracts obtained on days 7, 16, 19, and especially on day 28 postchallenge with PAN (2). About 85% of the total melanocyte-stimulating activity in the brownish guinea pig skin homogenate was found in the 105,000 × g supernatant (cytosolic) fraction at day 28 postchallenge, and the specific activity was the highest in this fraction (2). Therefore, we have now purified the melanogenic factors from the cytosolic fraction at day 28 postchallenge. When the cytosolic fraction was applied directly to a TSK 2000SW column, the elution profile exhibited three active fractions (fractions I, II, and III) with different molecular masses, as shown by the stimulation of DNA synthesis and melanogenesis by guinea pig melanocytes (Fig. 1). By contrast, similar gel chromatographic analyses of skin extracts (cytosolic fraction) obtained at day 0 postchallenge lack the 8-9-kDa fraction (fraction III) (data not shown), suggesting that PIMSF has a molecular mass of approximately 8-9 kDa. For this reason, we attempted to purify further the PIMSF from fraction III. Furthermore, because the biological activity of the stimulating factor was destroyed completely by heat (100 °C for 5 min) or by trypsin (37 °C for 30 min) (data not shown), it is considered to be a polypeptidic component. TSK 2000SW column chromatography was efficient in separating and purifying this PIMSF species, demonstrating about a 6-fold increase in its specific activity (step 3 in Table I). This PIMSF fraction was purified further by successive chromatographies on Mono Q (step 4), octadecyl-NPR (step 5), Mono Q (step 6, rechromatography), and TSK 2000SW (step 7, rechromatography) columns. Figs. 2 and 3 show the elution profiles of the Mono Q column rechromatography (step 6) and the TSK 2000SW column rechromatography (step 7), respectively. In the latter chromatograpy where various melanogenic factors were used as molecular marker and compared, the peak fraction with bioactivity is very similar in elution position to rat GRO-alpha (Fig. 3). At this final purification step (step 7), the specific bioactivity of PIMSF had been increased by 5,195-fold over the original skin homogenate (Table I). The purified active fraction from TSK 2000SW rechromatography gave a single band with an apparent molecular mass of 7.9 kDa when examined by SDS-PAGE (Fig. 4). Furthermore, the PIMSF is similar in molecular size to rat GRO-alpha (molecular mass of 7.9 kDa) upon SDS-PAGE.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Gel chromatographic purification (TSK 2000SW) of cytosolic factors from skin extracts following PAN allergy treatment. Melanogenic activities (melanin synthesis and tyrosinase activity) of each fraction were measured by 3H2O release into medium and incorporation of [14C]thiouracil into melanin. Mitogenic activity (DNA synthesis) was measured by incorporation of [3H]thymidine into cells. Melanocytes were incubated for 24 h with fractions at 100 µl/ml and assayed as detailed under "Experimental Procedures." Skin extract at day 28 postchallenge was used for this experiment.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of PIMSF from allergy-induced guinea pig epidermis
The bioactivities at each step of purification were determined by the increase in [3H]thymidine incorporation when each fraction was added to cultured guinea pig melanocytes. One unit of PIMSF activity was defined as the amount of activity which indicates an increase of 10,000 dpm of [3H]thymidine incorporation under the described conditions.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Elution profiles of Mono Q column rechromatography (at purification step 6). For details of the purification and assays, see "Experimental Procedures." For assay of DNA synthesis, 20 µl of 10-fold diluted samples of each fraction was applied to cultured guinea pig melanocytes (to a total volume of 500 µl).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   TSK 2000SW column rechromatography (at the final purification step 7). Elution positions of various melanogenic factors are shown by arrows. For assay of DNA synthesis, 20 µl of a 50-fold diluted sample of each fraction was applied to cultured guinea pig melanocytes (to a total volume of 500 µl). TGFalpha , transforming growth factor alpha ; EGF, epidermal growth factor.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 4.   SDS-PAGE of the purified active fraction from TSK 2000SW gel chromatography (step 7). The applied concentrations were 10 ng/lane for the purified PIMSF (lane 1) and rat GRO-alpha (lane 2). Migration of molecular mass standards is shown in kDa. Protein bands were visualized by means of Coomassie Blue staining. Molecular mass markers: 9.7, collagen peptide A; 6.6, aprotinin; 4.5, sauvagine; 3.1, secretin; 2.1, atriopeptin; 1.4, bacitracin.

We next determined whether the purified PIMSF has the potential to activate intracellular signal transduction systems such as Ins(1,4,5)IP3 formation and intracellular calcium mobilization in guinea pig melanocytes through ligand-receptor interaction. The purified PIMSF elicited a quick increase in Ins(1,4,5)IP3 levels within 40 s postincubation (Fig. 5). Although epidermal growth factor, transforming growth factor alpha , bFGF, and GM-CSF showed little or no significant effect on calcium mobilization (Table II), the purified PIMSF, ET-1, and rat GRO-alpha stimulated a marked increase in intracellular calcium mobilization in cultured guinea pig melanocytes (Fig. 6 and Table II). The calcium mobilization induced by purified PIMSF was perturbed by the prior addition of pertussis toxin (Fig. 7, A and B). In many cells, the production of Ins(1,4,5)IP3 is intrinsically accompanied by the generation of 1,2-diacylglycerol, which activates PKC through translocation modulation (6). Because membrane association of PKC is thought to represent an initial step in PKC activation, we have examined whether PIMSF has any effect on the redistribution of PKC. When purified PIMSF was added to cultured guinea pig melanocytes, a rapid translocation of PKC from the cytosol to the membrane was observed (Fig. 8). When guinea pig melanocytes were exposed to phorbol 12,13-dibutyrate for 20 h to down-regulate PKC activity, the stimulation of DNA synthesis and melanogenesis induced by PIMSF were suppressed markedly (Fig. 9, A-C). These findings suggested the involvement of PKC activation in PIMSF-mediated stimulation of melanogenesis by melanocytes even though the signal pathway via phosphorylation after PKC activation which leads to the melanogenic activation is not clearly understood. To characterize this further, the purified PIMSF was analyzed by immunoblotting and was found to cross-react with an anti-rat GRO-alpha antibody (Fig. 10). Although rat GRO-alpha was similar to PIMSF in its stimulatory effect on DNA synthesis in cultured guinea pig melanocytes, the mitogenic stimulation by PIMSF was abolished markedly by the addition of anti-rat GRO-alpha antibody but not by anti-bFGF or by anti-ET antibodies (Fig. 11). These results suggest that the purified PIMSF belongs to the GRO family or is very closely related to it.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Purified PIMSF increases Ins(1,4,5)IP3 levels in cultured guinea pig melanocytes. Melanocytes were stimulated with purified PIMSF at a 1 µg/ml concentration for the indicated times. The mass levels of Ins(1,4,5)IP3 were assayed as detailed under "Experimental Procedures." Bar, S.D. from three experiments.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Comparison of the purified PIMSF with other growth factors for effects on intracellular calcium mobilization
Calcium mobilization was assessed as described under "Experimental Procedures." right-arrow, no increase; up-arrow , increase.


View larger version (138K):
[in this window]
[in a new window]
 
Fig. 6.   Pseudocolor images of Fura-2 fluorescence intensity ratio imaging in guinea pig melanocytes at various times after stimulation with purified PIMSF. Melanocytes were loaded with the calcium indicator Fura-2/AM (2 µM) for 30 min at 37 °C in the MCM excluding PMA and cholera toxin. Fura-2/AM-loaded melanocytes were stimulated by purified PIMSF at a 1 µg/ml concentration. Fluorescence images were obtained at alternating excitation wavelengths of 340 and 380 nm through an SIT vidicon camera and were processed using an Argus-200 image analyzer.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   Purified PIMSF induces a marked stimulation of intracellular calcium mobilization in cultured guinea pig melanocytes (GPMC) (panel A) which can be inhibited by pretreatment with pertussis toxin (PT) (panel B). Melanocytes were loaded with the calcium indicator Fura-2/AM (2 µM) for 30 min at 37 °C in the MCM excluding PMA and cholera toxin. The assay for intracellular calcium mobilization was carried out in MEM without fetal calf serum. Pertussis toxin was added at a concentration of 100 ng/ml, 15 h before incubation with purified PIMSF. The purified PIMSF was added at a 1 µg/ml concentration. The arrow indicates when the purified PIMSF was added. The results are the ratio of the fluorescence emitted at 340 nm to that at 380 nm and represent the average curve from seven cells.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 8.   Purified PIMSF induces a rapid translocation of PKC from the cytosol to the membrane when added to cultured guinea pig melanocytes. Melanocytes were incubated with purified PIMSF (1 µg/ml) at 37 °C for the indicated periods. The cytosolic and membrane fractions were prepared as described previously (14). PKC activity was assayed by measuring the incorporation of 32P from [gamma -32P]ATP into histone H-1 (type III-S) as described elsewhere (14). Bar, S.D. from three experiments.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 9.   Stimulation of DNA synthesis (panel A) and melanogenesis (panels B and C) induced by PIMSF is markedly suppressed in the presence of phorbol 12,13-dibutyrate. 20 h before incubation with purified PIMSF (1 µg/ml), phorbol 12,13-dibutyrate (PdBU; 20 µM) was added to the guinea pig melanocyte cultures. Melanogenic activities (melanin synthesis and tyrosinase activity) of each fraction were measured by 3H2O release into medium and incorporation of [14C]thiouracil into melanin. Mitogenic activity (DNA synthesis) was measured by incorporation of ]3H]thymidine into cells. Melanocytes were incubated for 24 h with purified PIMSF and assayed as detailed under "Experimental Procedures." Bar, S.D. from three experiments.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 10.   Immunoblotting of purified PIMSF shows cross-reactivity with anti-rat GRO-alpha antibody. The applied concentrations were 10 ng/100 ml purified PIMSF (lane 1) and 10 ng/100 ml rat GRO-alpha (lane 2). Anti-rat GRO-alpha antibody was used at a concentration of 400 µg/ml. Molecular mass markers (in kDa): 9.7, collagen peptide A; 6.6, aprotinin; 4.5, sauvagine; 3.1, secretin; 2.1, atriopeptin; 1.4, bacitracin.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 11.   Mitogenic activities of purified PIMSF were abolished markedly by the addition of anti-GRO-alpha antibody but not by anti-bFGF or by anti-ET antibodies. Purified PIMSF or GRO-alpha and antibodies were mixed and added to the guinea pig melanocyte cultures. The applied concentrations were as follows (in µl/ml): PIMSF, 1; GRO-alpha , 1; anti-GRO-alpha , 100; anti-bFGF, 120; anti-ET-1, 90. Mitogenic activity (DNA synthesis) was measured by incorporation of [3H]thymidine into cells. Melanocytes were incubated for 24 h with purified PIMSF and assayed as detailed under "Experimental Procedures." Bar, S.D. from three experiments.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Recent studies suggest that paracrine linkage between melanocytes and surrounding cells in skin tissue such as keratinocytes and fibroblasts plays an important role in stimulating proliferation and melanogenesis of melanocytes, leading to epidermal hyperpigmentation (5, 7, 9). Keratinocytes and fibroblasts have been shown to secrete potent melanogenic stimulants for melanocytes in response to several stimuli, including chemicals, cytokines, and UV light (17). These findings provide us with deeper insights into the biological mechanisms of epidermal hyperpigmentation, especially those induced by UVA and B. We have recently identified ET-1 (7) and GM-CSF (9) as important melanogenic stimulants for UVB- and UVA-induced melanosis, respectively. However, little is known about biological mechanisms involved in hyperpigmentation induced by allergic inflammation because no related paracrine or autocrine melanogenic factors have been identified. In the case of UV-induced epidermal hyperpigmentation, we used a co-culture system consisting of melanocytes as responders and UV-irradiated keratinocytes as stimulators to detect secreted cytokines in keratinocytes after UV exposure and to determine intrinsic paracrine cytokines in melanocytes by neutralizing antibodies (7, 9). However, because allergic inflammatory processes could not be substantiated in such a culture system, we have attempted to isolate melanogenic factors from allergen-evoked skin tissue through bioassay of their melanogenic stimulation of cultured melanocytes. We demonstrated previously that PAN-induced late appearing hyperpigmentation in brownish guinea pig skin was associated with the specific appearance of an epidermal melanogenic soluble factor(s), which activates intracellular signal transduction through ligand-receptor interaction (2). In this study, we have now purified and characterized that PIMSF from hyperpigmented skin extracts. The PIMSF was purified to apparent homogeneity and shows a single band with an apparent molecular mass of 7.9 kDa upon SDS-PAGE. The PIMSF was similar in molecular profile to rat GRO-alpha (molecular mass of 7.9 kDa) (16) upon SDS-PAGE. Immunoblotting analysis revealed consistently that the purified PIMSF cross-reacted with an anti-GRO-alpha antibody and that the bioactivities of PIMSF could be abrogated by the addition of anti-GRO-alpha antibody. These findings suggest that purified PIMSF is identical to GRO families or is very closely related to them. Similarity of the purified PIMSF to the GRO protein is also corroborated by their comparable cellular effects, including their signal transduction profiles such that both induced a marked stimulation of DNA synthesis in cultured guinea pig melanocytes at similar concentrations, accompanied by release of inositol trisphosphate and intracellular calcium mobilization, which was in turn followed by PKC translocation (18). Therefore, it seems likely that melanogenic stimulation induced by PAN allergy is mediated by GRO-alpha secreted during biological processes subsequent to cutaneous allergic reaction.

GRO was identified originally as melanoma growth-stimulating activity for its ability to induce proliferation of human melanoma Hs294T cells (19); it is a member of a gene family encoding secretory proteins associated with the inflammatory response (20, 21). Structurally, GRO is related to a group of inflammatory proteins which includes interleukin-8 (IL-8), platelet factor 4, and beta -thromboglobulin (22). In addition to its ability to stimulate the proliferation of melanoma cells (19), GRO has a variety of other biological effects including the ability to act as a neutrophil chemotactic factor (23) and to induce calcium mobilization in a variety of different target cells (18). These biological relationships suggest that GRO may also have a function in the inflammatory response. This report demonstrates for the first time the ability of GRO-alpha to stimulate proliferation and melanogenesis of cultured melanocytes. This provides in vivo validation that keratinocytes, through GRO-alpha production and secretion, may play an important role in epidermal pigmentation. It has been reported that GRO-alpha mRNA is expressed in cultured human keratinocytes and that its expression is stimulated in response to UVB exposure (24) or to IL-1alpha treatment (25). In inflammatory and hyperproliferative skin diseases such as psoriasis, GRO-alpha mRNA is overexpressed selectively in the epidermis as a keratinocyte response to activated T cells (25). On the other hand, human foreskin fibroblasts express a 10-fold elevation in their steady-state levels of GRO mRNA in response to serum or PMA stimulation (26). It is interesting to note that IL-1 induces at least a 100-fold elevation of GRO mRNA expression without changing in c-myc or c-fos gene expression (26).

ET, which we have recently reported as a novel keratinocyte-derived mitogen and melanogen for human melanocytes in UVB-induced epidermal pigmentation (6-8), is very similar in its mode of action to purified PIMSF. ET-1 is stimulated in production and secretion from keratinocytes by the action of IL-1 in an autocrine fashion and activates the signal transduction pathway, including Ins(1,4,5)P3 formation, intracellular Ca2+ mobilization, and PKC in human melanocytes. In UVB-exposed keratinocytes, ET-1 is secreted with a lag time of a few days following IL-1 secretion (7), demonstrating a similar time course between ET secretion in culture and the onset of in vivo pigmentation following UVB irradiation. Significant differences between ET and GRO-alpha other than their molecular masses include the time course of their secretion in culture or in epidermal tissue. The production and secretion of ET-1 in cultured human keratinocytes require autocrine stimulation by IL-1alpha , which is released following UVB irradiation and which takes approximately 2-3 days to maximize (7). This time course of secretion is corroborated by the profile of ET-1 mRNA expression in culture (7) and in UVB-exposed human skin (8). On the other hand, the production or secretion of the PIMSF in guinea pig epidermis, estimated by melanogenic assay, was slight by day 20 postchallenge but became well defined by day 28 postchallenge. In our unpublished data,2 ET-activating factor activity, measured by fibroblast assay in epidermal homogenates during the late appearing pigmentation after PAN allergen challenge, was comparable in time course to PIMSF with a peak on day 28 postchallenge. Because several lines of evidence associate the initial process of GRO production by keratinocytes with the activation of the important primary cytokine, IL-1alpha cascade, including keratinocyte type 1 IL-1 receptor (25, 27), it is possible that the production or secretion of GRO-alpha in allergy-induced epidermis is triggered by the release of IL-1alpha . However, it remains unclear why a similar autocrine mechanism initiated by IL-1alpha secretion which leads to the secretion of GRO-alpha and ET-1 occurs in a different time course. Taken together, it seems likely that PAN allergy provides a new mechanism of hyperpigmentation in which biophysical factors, such as the GRO-alpha superfamily, synthesized within the epidermis, stimulate melanocytes through the activation of the PKC-related signal transduction system.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Biological Science Laboratories, Kao Corporation, Ichikaimachi 2606, Tochigi 321-34, Japan. Tel.: 285-68-7467; Fax: 285-68-7469; E-mail: 073733{at}kastanet.Kao.co.jp.

1 The abbreviations used are: PAN, phenylazonaphthol; PKC, protein kinase C; ET, endothelin(s); ET-1, endothelin-1; GM-CSF, granulocyte-macrophage colony-stimulating factor; GRO-alpha , growth-related oncogene alpha ; bFGF, basic fibroblast growth factor; MEM, minimal essential medium; PMA, phorbol 12-myristate 13-acetate; PIMSF, PAN-induced melanogenic stimulating factor; PBS, phosphate-buffered saline; Ins(1,4,5)P3, inositol 1,4,5-trisphosphate; PAGE, polyacrylamide gel electrophoresis; IL, interleukin.

2 G. Imokawa and M. Okuda, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Imokawa, G., and Kawai, M. (1987) J. Invest. Dermatol. 89, 540-546[Abstract]
  2. Imokawa, G., Yada, Y., and Okuda, M. (1992) J. Invest. Dermatol. 99, 482-488[Abstract]
  3. Nordlund, J. J., Collins, C. E., and Rhheins, L. A. (1986) J. Invest. Dermatol. 86, 433-437[Abstract]
  4. Imokawa, G., and Tejima, T. (1988) J. Invest. Dermatol. 92, 296-300[Abstract]
  5. Halaban, R., Langdon, R., Birchall, N., Cuono, C., Baurd, A., Scott, G., Moellmann, G., and McGuire, J. (1988) J. Cell Biol. 107, 1611-1619[Abstract]
  6. Yada, Y., Higuchi, K., and Imokawa, G. (1991) J. Biol. Chem. 266, 18352-18357[Abstract/Free Full Text]
  7. Imokawa, G., Yada, Y., and Miyagishi, M. (1992) J. Biol. Chem. 267, 24675-24680[Abstract/Free Full Text]
  8. Imokawa, G., Miyagishi, M., and Yada, Y. (1995) J. Invest. Dermatol. 105, 32-37[Abstract]
  9. Imokawa, G., Yada, Y., Kimura, M., and Morisaki, N. (1996) Biochem. J. 313, 625-631[Medline] [Order article via Infotrieve]
  10. Imokawa, G., Kawai, M., Mishima, Y., and Motegi, I. (1986) Arch. Dermatol. Res. 278, 352-362[Medline] [Order article via Infotrieve]
  11. Halaban, R. (1988) Pigment Cell Res. 1, 18-26
  12. Imokawa, G., Yada, Y., and Kimura, M. (1996) Biochem. J. 314, 305-312[Medline] [Order article via Infotrieve]
  13. Imokawa, G., and Motegi, I. (1993) J. Invest. Dermatol. 100, 47-54[Abstract]
  14. Yada, Y., Ozeki, T., Meguro, S., Mori, S., and Nozawa, Y. (1989) Biochem. Biophys. Res. Commun. 163, 1517-1522[Medline] [Order article via Infotrieve]
  15. Seishima, M., Yada, Y., Nagao, S., Mori, S., and Nozawa, Y. (1988) Biochem. Biophys. Res. Commun. 156, 1077-1082[Medline] [Order article via Infotrieve]
  16. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  17. Imokawa, G., Yada, Y., Morisaki, N., and Kimura, M. (1996) in Melanogenesis and malignant melanoma: Biochemistry, Cell Biology, Molecular Biology, Pathophysiology, Diagnosis, and Treatment (Hori, Y., Hearing, V. J., and Nakayama, J., eds), pp. 35-48, Elsevier Science, Amsterdam
  18. Richmond, A., Lawson, D. H., Nixon, D. W., Stevens, S., Chawla, R. K. (1983) Cancer Res. 43, 2106-2112[Abstract]
  19. Castor, C. W., Miller, J. W., and Walz, D. A. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 765-769[Abstract]
  20. Luster, A. D., Unkeless, J. C., and Ravetch, J. V. (1985) Nature 315, 672-676[Medline] [Order article via Infotrieve]
  21. Walz, A., Peveri, P., Aschauer, H., and Baggioline, M. (1987) Biochem. Biophys. Res. Commun. 149, 755-761[Medline] [Order article via Infotrieve]
  22. Derynck, R., Baalentien, E., Han, J. H., Thomas, H. G., Wen, D., Samantha, A. J., Zachariae, C. O., Griffin, P. R., Wong, W. L., Matsushima, K., Richmond, A. (1990) Biochemistry 29, 10225-10233[Medline] [Order article via Infotrieve]
  23. Moser, B., Schumacher, C., von Tscharner, V., Clark-Lewis, I., Baggiolini, M. (1991) J. Biol. Chem. 266, 10666-10671[Abstract/Free Full Text]
  24. Venner, T. J., Sauder, D. N., Feliciani, C., and Mckenzie, R. C. (1995) Exp. Dermatol. 4, 138-145[Medline] [Order article via Infotrieve]
  25. Kojima, T., Cromie, M. A., Fisher, G. J., Voorhees, J. J., Elder, J. T. (1993) J. Invest. Dermatol. 101, 767-772[Abstract]
  26. Anisowicz, A., Zajchowski, D., Stenman, G., and Sager, R. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9645-9649[Abstract]
  27. Groves, R. W., Rauschmayr, T., Nakamura, K., Sarkar, S., Williams, I. R., Kupper, T. S. (1996) J. Clin. Invest. 98, 336-344[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This Article
Abstract
Full Text (PDF)
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Imokawa, G.
Articles by Yada, Y.
Articles citing this Article
PubMed
PubMed Citation
Articles by Imokawa, G.
Articles by Yada, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.